Incivek is still in the experimental phase for individuals with Nicholson’s Genotype but has been shown to substantially increase the cure rate of Hep C patients with other Genotypes. Nicholson did a previous treatment from 09-10 that was not successful despite causing many side effects.
|Nurse Ann Port administering Devon’s first dose of Interferon at the Ottawa Civic Hospital|
Here you can watch an update from Devon as he leaves the Ottawa Civic Hospital after his first does of Interferon.
This entry was originally published on October 15, 2012. Reprinted with permission.